Tenn. Comp. R. & Regs. 0400-20-07-.25 - TRAINING FOR AN AUTHORIZED NUCLEAR PHARMACIST
Except as provided in Rule 0400-20-07-.26, a licensee shall require the authorized nuclear pharmacist to be a pharmacist who:
(1) Is certified by a specialty board whose
certification process has been recognized by the Division, the U.S. Nuclear
Regulatory Commission, or an Agreement State and who meets the requirements in
subparagraph (2)(b) of this rule. The names of board certifications that have
been recognized by the U.S. Nuclear Regulatory Commission or an Agreement State
are posted on the U.S. Nuclear Regulatory Commission's Medical Uses Licensee
Toolkit Web page. To have its certification process recognized, a specialty
board shall require all candidates for certification to:
(a) Have graduated from a pharmacy program
accredited by the Accreditation Council for Pharmacy Education (ACPE)
(previously named the American Council on Pharmaceutical Education) or have
passed the Foreign Pharmacy Graduate Examination Committee (FPGEC)
examination;
(b) Hold a current,
active license to practice pharmacy;
(c) Provide evidence of having acquired at
least 4,000 hours of training/experience in nuclear pharmacy practice. Academic
training may be substituted for no more than 2,000 hours of the required
training and experience; and
(d)
Pass an examination in nuclear pharmacy administered by diplomates of the
specialty board that assesses knowledge and competency in procurement,
compounding, quality assurance, dispensing, distribution, health and safety,
radiation safety, provision of information and consultation, monitoring patient
outcomes, research and development; or
(2)
(a) Has
completed 700 hours in a structured educational program consisting of both:
1. 200 hours of classroom and laboratory
training in the following areas:
(i)
Radiation physics and instrumentation;
(ii) Radiation protection;
(iii) Mathematics pertaining to the use and
measurement of radioactivity;
(iv)
Chemistry of radioactive material for medical use; and
(v) Radiation biology;
and
2. Supervised
practical experience in a nuclear pharmacy involving:
(i) Shipping, receiving, and performing
related radiation surveys;
(ii)
Using and performing checks for proper operation of instruments used to
determine the activity of dosages, survey meters, and, if appropriate,
instruments used to measure alpha- or beta-emitting radionuclides;
(iii) Calculating, assaying, and safely
preparing dosages for patients or human research subjects;
(iv) Using administrative controls to avoid
misadministrations in the administration of radioactive material; and
(v) Using procedures to prevent or minimize
radioactive contamination and using proper decontamination procedures;
and
(b) Has
obtained written attestation, signed by a preceptor authorized nuclear
pharmacist, that the individual has satisfactorily completed the requirements
in subparagraph (2)(a) of this rule is able to independently fulfill the
radiation safety-related duties as an authorized nuclear pharmacist.
Notes
Authority: T.C.A. ยงยง 4-5-201, et seq.; 68-202-101, et seq.; and 68-202-201, et seq.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.